Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Massa D, Foukakis T, Giacchetti S, Desmedt C, Frenel JS, Gasparini E, Kok M, Vigneri P, Jacot W, Vernieri C, Lambertini M, Patanè F, Piacentini F, Bria E, Zambelli A, Trapani D, Botticelli A, Garrone O, Lando S, Matikas A, Someil L, Floris G, Campone M, Ragazzi M, Lips E, Martorana F, Bonomi G, Papakonstantinou A, Nicolè L, Zerdes I, Neven P, Rotolo M, Horlings H, Nucera S, Gudin-De-Vallerin A, Vingiani A, Dei Tos AP, Guarneri V, Dieci MV, GAMBIT Consortium

Open source

DOI
10.1038/s41467-026-74056-2
Published
2026 Jun 24
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-74056-2,
  title = {Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.},
  author = {Massa D and Foukakis T and Giacchetti S and Desmedt C and Frenel JS and Gasparini E and Kok M and Vigneri P and Jacot W and Vernieri C and Lambertini M and Patanè F and Piacentini F and Bria E and Zambelli A and Trapani D and Botticelli A and Garrone O and Lando S and Matikas A and Someil L and Floris G and Campone M and Ragazzi M and Lips E and Martorana F and Bonomi G and Papakonstantinou A and Nicolè L and Zerdes I and Neven P and Rotolo M and Horlings H and Nucera S and Gudin-De-Vallerin A and Vingiani A and Dei Tos AP and Guarneri V and Dieci MV and GAMBIT Consortium},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-74056-2},
  url = {https://doi.org/10.1038/s41467-026-74056-2}
}

RIS

TY  - JOUR
TI  - Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.
AU  - Massa D
AU  - Foukakis T
AU  - Giacchetti S
AU  - Desmedt C
AU  - Frenel JS
AU  - Gasparini E
AU  - Kok M
AU  - Vigneri P
AU  - Jacot W
AU  - Vernieri C
AU  - Lambertini M
AU  - Patanè F
AU  - Piacentini F
AU  - Bria E
AU  - Zambelli A
AU  - Trapani D
AU  - Botticelli A
AU  - Garrone O
AU  - Lando S
AU  - Matikas A
AU  - Someil L
AU  - Floris G
AU  - Campone M
AU  - Ragazzi M
AU  - Lips E
AU  - Martorana F
AU  - Bonomi G
AU  - Papakonstantinou A
AU  - Nicolè L
AU  - Zerdes I
AU  - Neven P
AU  - Rotolo M
AU  - Horlings H
AU  - Nucera S
AU  - Gudin-De-Vallerin A
AU  - Vingiani A
AU  - Dei Tos AP
AU  - Guarneri V
AU  - Dieci MV
AU  - GAMBIT Consortium
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-74056-2
UR  - https://doi.org/10.1038/s41467-026-74056-2
ER  - 

APA

D, M., T, F., S, G., C, D., JS, F., E, G., M, K., P, V., W, J., C, V., M, L., F, P., F, P., E, B., A, Z., D, T., A, B., O, G., S, L., A, M., L, S., G, F., M, C., M, R., E, L., F, M., G, B., A, P., L, N., I, Z., P, N., M, R., H, H., S, N., A, G., A, V., AP, D. T., V, G., MV, D., & Consortium, G. (2026). Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.. Nature communications. https://doi.org/10.1038/s41467-026-74056-2

Source records